Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Walid Gellad, a professor of medicine at the University of Pittsburgh who studies medication adherence
Later studies have reported weight loss approaching 28% in some participants, which is comparable to results sometimes seen with bariatric surgery
reports honoraria and/or consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Merck Sharp & Dohme, Novartis, Novo Nordisk, Recardio, Sanofi, Sanova and Vaxxinity
PMID: 7592866
Flatlined support- Lack of standardized ranges for healthy individuals Flatlined support- Lack of standardized ranges for healthy individuals In a recent survey study conducted among healthcare professionals, findings pointed to the need for future work to develop CGM criteria for identifying potentially high-risk individuals who may progress to prediabetes or type 2 diabetes (Spartano et al 2025)
US$ 25.33
US$ 27.81
US$ 21.60
